Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Sihuan Pharmaceutical Holdings Group Ltd. ?
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 84.51%, its profits have fallen by -20.7%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sihuan Pharmaceutical Holdings Group Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sihuan Pharmaceutical Holdings Group Ltd.
84.51%
2.73
55.60%
Hang Seng Hong Kong
27.36%
1.03
25.88%
Quality key factors
Factor
Value
Sales Growth (5y)
-2.18%
EBIT Growth (5y)
-193.65%
EBIT to Interest (avg)
7.73
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.33
Tax Ratio
10.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.59%
ROE (avg)
1.99%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.93
EV to EBIT
-23.79
EV to EBITDA
-60.16
EV to Capital Employed
6.77
EV to Sales
5.11
PEG Ratio
NA
Dividend Yield
0.68%
ROCE (Latest)
-28.46%
ROE (Latest)
-11.07%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Sihuan Pharmaceutical Holdings Group Ltd.
Inventory Turnover Ratio
Highest at 1.11%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by 1.41% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
At HKD 138.95 MM has Grown at 8.23%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Sihuan Pharmaceutical Holdings Group Ltd.
Operating Cash Flow
Lowest at HKD 707.83 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (HKD MM)
Interest
Highest at HKD 154.55 MM
in the last five periods and Increased by 7.68% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Pre-Tax Profit
Fallen at -55.35%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Cash and Eqv
Lowest at HKD 4,125.29 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -66.32 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






